| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2023 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 200k | $7.08 | $1.4M | | 08/17/2023 |
| 05/02/2023 | Edgewise Therapeutics, Inc. | | Sale | Common Stock | 1.3k | $8.90 | $11.9k | | 05/01/2023 |
| 05/01/2023 | Edgewise Therapeutics, Inc. | | Exercise | Restricted Stock Units | 5.2k | $0.00 | $0 | | 05/01/2023 |
| 08/08/2022 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 200k | $10.39 | $2.1M | | 08/08/2022 |
| 06/17/2022 | Elevation Oncology, Inc. | ELEV | Grant | Stock Option (Right to Buy) | 15.6k | $1.31 | $20.5k | | 06/17/2022 |
| 05/23/2022 | Edgewise Therapeutics, Inc. | | Exercise | Stock Option (Right to Buy) | 9k | $0.71 | $6.4k | | 05/23/2022 |
| 05/01/2022 | Edgewise Therapeutics, Inc. | | Grant | Restricted Stock Units | 15.6k | $0.00 | $0 | | 05/01/2022 |
| 08/17/2021 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 120k | $16.38 | $2M | | 08/17/2021 |
| 03/16/2020 | Fresh Tracks Therapeutics, Inc. | VICL | Grant | Restricted Stock Units | 10k | $1.54 | $15.4k | | 03/16/2020 |
| 01/12/2017 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to Buy) | 200k | $0.00 | $0 | | 01/12/2017 |